Population
Cancer survivors and cellular targets (cardiomyocytes, cardiac progenitor cells, undifferentiated cells)
Design
Review
Authors
Loading...
May inform multi-cellular cardioprotection strategies; leaves open clinical translation pending prospective trials.
Understanding the broader cellular targets of doxorubicin, including cardiac progenitor cells, may promote new experimental and clinical cardioprotective strategies.
Angelis et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: